Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D01IGL
|
||||
| Former ID |
DNC009201
|
||||
| Drug Name |
(+/-)-3-allyl-1-pent-4-enoylazetidin-2-one
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [529529] | ||
| Formula |
C11H15NO2
|
||||
| Canonical SMILES |
C=CCCC(=O)N1CC(C1=O)CC=C
|
||||
| InChI |
1S/C11H15NO2/c1-3-5-7-10(13)12-8-9(6-4-2)11(12)14/h3-4,9H,1-2,5-8H2
|
||||
| InChIKey |
QVTWEMBUZOBMIJ-UHFFFAOYSA-N
|
||||
| PubChem Compound ID | |||||
| Target and Pathway | |||||
| Target(s) | Fatty-acid amide hydrolase | Target Info | Inhibitor | [529529] | |
| BioCyc Pathway | Anandamide degradation | ||||
| KEGG Pathway | Retrograde endocannabinoid signaling | ||||
| PANTHER Pathway | Anandamide degradation | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.